We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current AYTU market cap is 14.81M. The company's latest EPS is USD -3.0625 and P/E is -0.87.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 27.66M | 26.28M | 22.73M | 30.73M | 22.1M |
| Operating Income | -1.65M | -4.19M | -9.29M | 2.81M | -1.5M |
| Net Income | -2.88M | -4.51M | -7.2M | -2.46M | -8.12M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 7.32M | 27.63M | 65.63M | 96.67M | 107.4M |
| Operating Income | -16.85M | -21.13M | -58.87M | -111.56M | -12.33M |
| Net Income | -27.13M | -13.62M | -58.29M | -110.17M | -17.05M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 150M | 141.44M | 147.22M | 136.46M | 132.89M |
| Total Liabilities | 96.09M | 95.62M | 106.3M | 97.11M | 100.72M |
| Total Equity | 53.91M | 45.82M | 40.91M | 39.36M | 32.17M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 34.72M | 152.84M | 265.67M | 137.62M | 136.46M |
| Total Liabilities | 27.63M | 57.82M | 128.1M | 91.53M | 97.11M |
| Total Equity | 7.09M | 95.02M | 137.57M | 46.09M | 39.36M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.15M | -11.59M | -14.49M | -5.13M | -211k |
| Investing | 42k | 37k | 38k | -117k | -76k |
| Financing | 13.56M | 11.69M | 14.28M | 8.87M | -2.73M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -13.83M | -28.37M | -25.96M | -28.82M | -5.13M |
| Investing | -1.06M | -5.66M | -2.78M | -3.25M | -117k |
| Financing | 19.08M | 71.07M | 30.31M | 1.53M | 8.87M |
| Market Cap | 14.81M |
| Price to Earnings Ratio | -0.87 |
| Price to Sales Ratio | 0.14 |
| Price to Cash Ratio | 0.64 |
| Price to Book Ratio | 0.38 |
| Dividend Yield | - |
| Shares Outstanding | 5.57M |
| Average Volume (1 week) | 6.05k |
| Average Volume (1 Month) | 16.65k |
| 52 Week Change | 1.92% |
| 52 Week High | 3.50 |
| 52 Week Low | 1.38 |
| Spread (Intraday) | 0.19 (6.64%) |
| Company Name | AYTU BioPharma Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.aytubio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
